An evaluation of the ability of thrombospondin-1 to predict stroke outcomes and mortality after ischemic stroke
| Autor: | Firas Alfwaress, Ahmed Alhusban, Majdi Al Qawasmeh |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
endocrine system business.industry Angiogenesis General Neuroscience virus diseases General Medicine Bioinformatics medicine.disease Extracellular matrix 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Thrombospondin 1 Ischemic stroke Medicine business Stroke 030217 neurology & neurosurgery |
| Zdroj: | International Journal of Neuroscience. 132:507-510 |
| ISSN: | 1543-5245 0020-7454 |
| DOI: | 10.1080/00207454.2020.1825417 |
| Popis: | Thrombspondin-1 (TSP-1) is a glycoprotein that has a variety of functions including suppression of angiogenesis and regulation of extracellular matrix deposition. These functions are central to the recovery process after stroke. Data regarding the association and predictive value of TSP-1 and stroke outcomes are limited.Patients with ischemic stroke who referred to King Abdullah University Hospital were evaluated for inclusion. The level of serum TSP-1 on admission was assayed using ELISA. Data regarding comorbid diseases as well as stroke severity at baseline, functional outcome and mortality at 6 months were collected prospectively. Favorable outcome was identified as NIHSS or mRS ≤ 1.Ninety-six patients with an average age of 66.7 years were included. One-third of the patients (32 patients) had favorable outcome on admission. The serum TSP-1 levels in patients with favorable outcome were significantly higher (719.7 vs. 639.9;TSP-1 can predict favorable outcomes with regard to the initial severity and long-term functional outcome. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|